LILLY GZMR
Who is this for?
Those with uncontrolled asthma with a BMI over 22
Study:
This study looks at the GLP-1/GIP agonist, Brenipatide. It evaluates the effectiveness of different doses of Brenipatide to manage asthma symptoms.
Those with uncontrolled asthma with a BMI over 22
This study looks at the GLP-1/GIP agonist, Brenipatide. It evaluates the effectiveness of different doses of Brenipatide to manage asthma symptoms.